EMBRYONAL TUMOR WITH MULTILAYERED ROSETTES
Clinical trials for EMBRYONAL TUMOR WITH MULTILAYERED ROSETTES explained in plain language.
Never miss a new study
Get alerted when new EMBRYONAL TUMOR WITH MULTILAYERED ROSETTES trials appear
Sign up with your email to follow new studies for EMBRYONAL TUMOR WITH MULTILAYERED ROSETTES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for kids with rare cancers: drug combo trial launches
Disease control Recruiting nowThis study tests an experimental oral drug called AMXT 1501 combined with another drug, eflornithine (DFMO), in children and young adults up to age 21 with certain cancers like neuroblastoma, brain tumors, and sarcomas. The first part finds the safest dose, and the second part ch…
Matched conditions: EMBRYONAL TUMOR WITH MULTILAYERED ROSETTES
Phase: PHASE1, PHASE2 • Sponsor: Milton S. Hershey Medical Center • Aim: Disease control
Last updated May 17, 2026 07:02 UTC
-
Custom immune cells take aim at childhood brain cancers
Disease control Recruiting nowThis early-phase study tests a personalized treatment for children under 5 with certain brain tumors. Doctors take a patient's own immune cells, train them to recognize unique markers from their tumor, and give them back to fight the cancer. The goal is to see if this approach is…
Matched conditions: EMBRYONAL TUMOR WITH MULTILAYERED ROSETTES
Phase: PHASE1 • Sponsor: Children's National Research Institute • Aim: Disease control
Last updated May 17, 2026 06:51 UTC
-
New hope for kids with rare brain cancer: aggressive combo therapy trial launches
Disease control Recruiting nowThis study is for children newly diagnosed with a very rare and aggressive brain tumor called ETMR. It tests a treatment plan that uses strong chemotherapy drugs and focused radiation to try to stop the tumor from growing. The goal is to see if this approach can help children liv…
Matched conditions: EMBRYONAL TUMOR WITH MULTILAYERED ROSETTES
Phase: PHASE2 • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
New hope for toddlers with rare brain cancers: targeted chemo trial launches
Disease control Recruiting nowThis early-phase study tests whether adding a chemotherapy drug (topotecan) given directly into the spinal fluid, followed by maintenance chemo, is safe and feasible for children under 6 with high-risk embryonal brain tumors. About 15 children will participate. The goal is to see…
Matched conditions: EMBRYONAL TUMOR WITH MULTILAYERED ROSETTES
Phase: EARLY_PHASE1 • Sponsor: C17 Council • Aim: Disease control
Last updated May 12, 2026 13:48 UTC